Stock Events

Stock Events

Compass Therapeutics 

$5.43
25
+$0.14+2.65% Wednesday 20:00

Statistics

Day High
5.51
Day Low
5.11
52W High
6.88
52W Low
1.4
Volume
1,847,101
Avg. Volume
2,246,311
Mkt Cap
965.79M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

13MayExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-0.14
-0.12
-0.1
-0.08
Expected EPS
-0.098231
Actual EPS
N/A

Financials

-5,808.82%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
1.7MRevenue
-98.75MNet Income

Analyst Ratings

$15.00Average Price Target
The highest estimate is 30.00.
From 6 ratings within the last 6 months. This is not an investment recommendation.
Buy
83%
Hold
17%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CMPX. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Regeneron Pharmaceuticals
REGN
Mkt Cap68.5B
Regeneron Pharmaceuticals competes in the biotechnology field focusing on immunology and oncology, similar to Compass Therapeutics' focus on antibody discovery and development.
AMGEN
AMGN
Mkt Cap160.66B
Amgen is a biopharmaceutical company that develops therapeutics in areas overlapping with Compass Therapeutics, including cancer and inflammatory diseases.
Gilead Sciences
GILD
Mkt Cap148.78B
Gilead Sciences operates in the discovery, development, and commercialization of innovative therapeutics in areas like oncology, closely competing with Compass Therapeutics.
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Bristol Myers Squibb is involved in discovering, developing, and delivering innovative medicines that help patients prevail over serious diseases, including cancer, directly competing with Compass Therapeutics.
Merck
MRK
Mkt Cap214.76B
Merck & Co., Inc. focuses on pharmaceutical innovations including cancer treatments and immunotherapy, areas that Compass Therapeutics is also involved in.
Pfizer
PFE
Mkt Cap140.15B
Pfizer is a global biopharmaceutical company that has a broad range of drug development including oncology and immunology, competing with Compass Therapeutics.
Novartis
NVS
Mkt Cap237.61B
Novartis AG focuses on patented medicines in areas including oncology, directly competing with Compass Therapeutics in the field of innovative cancer therapies.
Roche
RHHBY
Mkt Cap258.9B
Roche Holding AG is a major player in pharmaceuticals and diagnostics with a strong focus on oncology and immunotherapy, making it a direct competitor to Compass Therapeutics.
Astrazeneca
AZN
Mkt Cap256.58B
AstraZeneca operates in several therapeutic areas including oncology, respiratory, cardiovascular, and immunotherapy, competing with Compass Therapeutics' focus areas.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson, through its pharmaceutical segment Janssen, develops treatments for a wide range of diseases including cancer, competing with Compass Therapeutics in the oncology space.

About

Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascular endothelial growth factor A signaling pathways, which are critical to angiogenesis and tumor vascularization; and CTX-471, an IgG4 monoclonal antibody that is an agonist of CD137. Its product candidates also comprise CTX-8371, a bispecific inhibitor that targets PD-1 and PD-L1. The company was founded in 2014 and is headquartered in Boston, Massachusetts.
Show more...
CEO
Dr. Thomas J. Schuetz M.D., Ph.D.
Employees
35
Country
US
ISIN
US20454B1044

Listings

XNAS
US
CMPX
BOATS
BOATS
CMPX.BOATS

0 Comments

Share your thoughts

FAQ

What is Compass Therapeutics stock price today?▼
The current price of CMPX is $5.43 USD — it has increased by +2.65% in the past 24 hours. Watch Compass Therapeutics stock price performance more closely on the chart.
What is Compass Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Compass Therapeutics stocks are traded under the ticker CMPX.
Is Compass Therapeutics stock price growing?▼
CMPX stock has risen by +1.88% compared to the previous week, the month change is a -4.4% fall, over the last year Compass Therapeutics has showed a +221.3% increase.
What is Compass Therapeutics market cap?▼
Today Compass Therapeutics has the market capitalization of 965.79M
When is the next Compass Therapeutics earnings date?▼
Compass Therapeutics is going to release the next earnings report on May 13, 2026.
What were Compass Therapeutics earnings last quarter?▼
CMPX earnings for the last quarter are -0.09 USD per share, whereas the estimation was -0.09 USD resulting in a +4.22% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Compass Therapeutics revenue for the last year?▼
Compass Therapeutics revenue for the last year amounts to 1.7M USD.
What is Compass Therapeutics net income for the last year?▼
CMPX net income for the last year is -98.75M USD.
How many employees does Compass Therapeutics have?▼
As of April 02, 2026, the company has 35 employees.
In which sector is Compass Therapeutics located?▼
Compass Therapeutics operates in the Health Care sector.
When did Compass Therapeutics complete a stock split?▼
Compass Therapeutics has not had any recent stock splits.
Where is Compass Therapeutics headquartered?▼
Compass Therapeutics is headquartered in Boston, US.